After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to ...
Proteus Biomedical announced today that it has received a patent for its ingestible biomedical sensor -- what the company has referred to as "intelligent medicine" in the past and what many have ...
The US Food and Drug Administration (FDA) has accepted for review what is being considered the first new drug application (NDA) for a combination product to include a sensor embedded into the tablet.